Pharmat
Timeline
13 events since 2020Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 21 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0757528329
Annual accounts 2024 filed PDFmicro format · 28 days late
2024
Highest result from 2021 to 2025 net €116,356 ▲26.7% The operating result of €130,402 and the net result of €116,356 are both a record.
Liquidity more than 9 times current ratio 32.53 The current ratio rises from 3.53 to 32.53. Short-term debt falls from €81,069 to €10,502.
Annual accounts 2023 filed PDFmicro format · 28 days late
2023
Equity above €200,000 equity €216,571 ▲35% With a profit in every financial year since 2021, equity grows to €216,571.
Annual accounts 2022 filed PDFmicro format · 29 days late
2022
Liquidity doubles current ratio 4.20 The current ratio rises from 2.07 to 4.20. Short-term debt falls from €56,252 to €44,293.
Equity above €150,000 equity €160,432 ▲114% With a profit in every financial year since 2021, equity grows to €160,432.
Annual accounts 2021 filed PDFmicro format · 26 days late
2020
IncorporationFounding capital of €2,500 · Founder: VAN LAETHEM Matthias Thomas · Appointment: VAN LAETHEM Matthias Thomas (director) · published on 29-10-20203 points ▸
- Founder, VAN LAETHEM Matthias Thomas
- Director appointment, VAN LAETHEM Matthias Thomas (director (not named in the articles))
- Founding capital, €2,500
- The deed holds 3 more points.
First establishment Vrouweneekhoekstraat 122, Sint-Niklaas
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 27 October 2020, Pharmat was incorporated as a private limited company by one natural person, with a starting capital of €2,500.12 VAN LAETHEM Matthias Thomas has served as director since 2020.3 Total assets went from €131,396 in 2021 to €448,864 in 2025.4